Article Text

Download PDFPDF
Inguinal lymph node metastasis in treated breast cancer: an extremely rare presentation and review of literature
  1. Saroj Kumar Das Majumdar1,
  2. Anupam Muraleedharan1,
  3. Bikash Ranjan Mahapatra1 and
  4. Amit Kumar Adhya2
  1. 1Department of Radiotherapy, All India Institute of Medical Sciences Bhubaneswar, Bhubaneswar, Odisha, India
  2. 2Department of Pathology, All India Institute of Medical Sciences Bhubaneswar, Bhubaneswar, Odisha, India
  1. Correspondence to Dr Bikash Ranjan Mahapatra; drbikashranjan1988{at}gmail.com

Abstract

Metastasis to inguinal lymph nodes from breast cancer is extremely rare and only a handful of cases have been reported in the literature to date. We report a case of a postmenopausal female patient who was a treated case of right breast cancer and developed inguinal metastases after 9 months. An excisional biopsy of the lesion confirmed the diagnosis. A positron emission tomography–CT scan revealed retropectoral and pelvic lymphadenopathy. The patient was treated with palliative radiotherapy to the inguinal and pelvic regions followed by palliative chemotherapy. The patient survived for 4 months after the detection of inguinal metastasis.

  • Cancer intervention
  • Breast cancer
  • Chemotherapy
  • Radiotherapy
  • Pain (palliative care)

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors BRM acknowledge the contributions given by the following authors. SKD—identified the rarity of the case, collected the data, has seen and approved the final manuscript and accepts responsibility for the entire process. AM—was part of the radiotherapy treatment team, collected the data, has seen and approved the final manuscript and accepts responsibility for the entire process. BRM—was part of the chemotherapy team, collected the data, wrote the first draft and has seen and approved the final manuscript. AKA—was part of the pathology team, collected data and has seen and approved the final manuscript.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Case reports provide a valuable learning resource for the scientific community and can indicate areas of interest for future research. They should not be used in isolation to guide treatment choices or public health policy.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.